Better Questions.
Clearer Decisions.
Fasolati’s ambition is to make oral, gut and systemic research useful—without turning a promising mechanism into a personal health claim before the evidence is there.
Thad Connelly
Thad Connelly is an oral and maxillofacial surgeon and the founder of Gengyve. Fasolati brings an oral-health starting point to a broader research and product-development direction.
View the UCSF Dental Center faculty profile →
The central question: can better measurement of oral bacterial activity add useful information beyond routine examination and existing measures—and help justify a better next step?
Make the Next Step More Informed
We want fewer demands on the person and more discipline in the engine. Oral, gut and systemic observations belong in a connected research program, but they should keep their own meaning rather than disappear into one averaged score.
Evidence Before Inference
Our standard is to distinguish a measured result, a validated association, an experimental mechanism and an untested hypothesis.
Uncertainty in View
The proposed Life Board should answer what changed, how confident we are and what next step is justified—including when a result is not interpretable yet.
Clinical Judgment Matters
Development concepts are not instructions for care. The intended role is to support informed discussion, not automate prescribing or replace dental and medical evaluation.
Outcomes Over a Story
We aim to test defined interventions against meaningful outcomes, retain unfavorable results and change the model when the evidence calls for it.
Build What the Evidence Can Support
The research priorities are to define the analyte, establish repeatable measurement, test whether it adds information beyond simpler measures, and evaluate the finished intervention. These are development gates, not completed milestones.
Loria has a product-information inquiry path. Lytica, the Gut Stack and the Life Board have distinct development questions. A shared brand does not give them a shared efficacy claim.